Additionally, because BRCA1 deficient cells have a defect in the G2/M checkpoint [45], our cell cycle studies showing that MMC-treated BCR/ABL cells are not arrested in G2/M - as it is characteristic of FA cells[26] - further suggest the role of BRCA1 in the interference of the FA pathway in these cells. Here, ABL1 is linked to Friedreich ataxia.